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Introduction
Abnormal accumulation of misfolded and aggregated protein 
in affected neurons is a hallmark of many neurodegenerative 
diseases associated with aging. The major pathways of protein 
clearance in the cell are performed by the proteasome and the 
lysosome, which both become compromised with age (Cuervo 
et al., 2005; Martinez-Vicente and Cuervo, 2007; Chondrogianni 
and Gonos, 2008; Tonoki et al., 2009). Parallel with reduced 
turnover, proteins mutated in familial neurodegenerative 
diseases accumulate and cause dysfunction and death, and 
accompanying symptoms. Examples include the polyglutamine 
(polyQ) disease protein Huntingtin (Htt) in Huntington’s 
disease (HD), tau in frontotemporal dementias (FTD), -synuclein 
in Parkinson’s disease (PD), ataxin-1 in spinocerebellar ataxia 
1 (SCA1), and SOD1 in amyotrophic lateral sclerosis (ALS).
Post-translational modification of target proteins can 
regulate their clearance from cells. Phosphorylation regulates 
protein degradation, alters subcellular localization, and/or creates 
phosphodegrons/binding motifs for interactors that regulate 
secondary modifications such as ubiquitination, SUMOylation, 
and acetylation. For instance, phosphorylation of HSF1, MEF2, 
 Expansion of the polyglutamine repeat within the protein Huntingtin (Htt) causes Huntington’s dis-ease, a neurodegenerative disease associated with 
aging and the accumulation of mutant Htt in diseased 
neurons. Understanding the mechanisms that influence 
Htt cellular degradation may target treatments designed 
to activate mutant Htt clearance pathways. We find 
that Htt is phosphorylated by the inflammatory kinase IKK, 
enhancing its normal clearance by the proteasome and 
lysosome. Phosphorylation of Htt regulates additional 
post-translational modifications, including Htt ubiquitina-
tion, SUMOylation, and acetylation, and increases Htt nu-
clear localization, cleavage, and clearance mediated by 
lysosomal-associated membrane protein 2A and Hsc70. 
We propose that IKK activates mutant Htt clearance until 
an age-related loss of proteasome/lysosome function pro-
motes accumulation of toxic post-translationally modified 
mutant Htt. Thus, IKK activation may modulate mutant Htt 
neurotoxicity depending on the cell’s ability to degrade 
the modified species.
IKK phosphorylates Huntingtin and targets it for 
degradation by the proteasome and lysosome
Leslie Michels Thompson,1,2,3 Charity T. Aiken,4 Linda S. Kaltenbach,7 Namita Agrawal,4 Katalin Illes,1  
Ali Khoshnan,8 Marta Martinez-Vincente,9,10 Montserrat Arrasate,11 Jacqueline Gire O’Rourke,3 Hasan Khashwji,2 
Tamas Lukacsovich,4 Ya-Zhen Zhu,1 Alice L. Lau,1 Ashish Massey,9 Michael R. Hayden,12 Scott O. Zeitlin,13  
Steven Finkbeiner,14 Kim N. Green,2 Frank M. LaFerla,2 Gillian Bates,15 Lan Huang,4,5 Paul H. Patterson,8  
Donald C. Lo,7 Ana Maria Cuervo,9 J. Lawrence Marsh,4,6 and Joan S. Steffan1
1Department of Psychiatry and Human Behavior, 2Department of Neurobiology and Behavior, 3Department of Biological Chemistry, 4Department of Developmental and Cell 
Biology, 5Department of Physiology and Biophysics, and 6Department of Pathology and Developmental Biology Center, University of California, Irvine, Irvine, CA 92697
7Center for Drug Discovery and Department of Neurobiology, Duke University, Durham, NC 27704
8California Institute of Technology, Pasadena, CA 91125
9Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY 10461
10Institute of Neuropathology, IDIBELL-Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, 08907 Barcelona, Spain
11Division of Neuroscience, Center for Applied Medical Research, University of Navarra, E-31008 Pamplona, Spain
12University of British Columbia, Vancouver, BC, Canada V6T 1Z4
13Department of Neuroscience, University of Virginia, Charlottesville, VA 22908
14Departments of Neurology and Physiology, Gladstone Institute of Neurological Disease, University of California, San Francisco, San Francisco, CA 94158
15Department of Medical and Molecular Genetics, King’s College London School of Medicine, King’s College London, London SE1 9RT, England, UK
© 2009 Thompson et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication 
date (see http://www.jcb.org/misc/terms.shtml). After six months it is available under a 
Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, 
as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
IO
L
O
G
Y
 o
n
 January 8, 2010 
jcb.rupress.org
D
ow
nloaded from
 
 Published December 21, 2009
 http://jcb.rupress.org/cgi/content/full/jcb.200909067/DC1
Supplemental Material can be found at: 
JCB • VOLUME 187 • NUMBER 7 • 2009 1084
Results
The IKK complex directly  
phosphorylates Htt
The N-terminal 17 amino acids of Htt contain a number of 
potentially modifiable residues (Fig. 1 A). In addition to the 
lysines at 6, 9, and 15, which can be SUMO modified and ubiq-
uitinated (Steffan et al., 2004), three residues are possible phos-
phorylation targets (T3, S13, and S16).
Sequence evaluation for conserved motifs revealed that 
Htt residues 11–18 share sequence similarity with residues 
642–649 of FOXO3a (Fig. 1 B), a substrate of IKK at S644 
analgous to Htt S13 (Hu et al., 2004). Because expanded polyQ 
Httex1p activates the IKK complex in cell culture and transgenic 
mice, and interacts with IKK- in vitro (Khoshnan et al., 2004), 
IKK emerged as a candidate kinase that might target Htt S13. 
IB kinase (IKK) is composed of three subunits: IKK- and 
IKK- are homologous catalytic subunits, and IKK- is a regu-
latory subunit. As a first step to evaluate phosphorylation of this 
domain and a potential role for IKK, mass spectrometry was 
used. 25QP-HBH, a His-tagged unexpanded form of Httex1p 
was transiently cotransfected with IKK- into ST14A cells, 
purified by nickel enrichment under denaturing conditions, di-
gested with chymotrypsin, and analyzed by reverse-phase liquid 
chromatography coupled to tandem mass spectrometry. Phos-
phorylation of both S13 and S16 was observed in the presence 
of IKK (Fig. 1 C).
Using Htt peptides phosphorylated at either S13 or S16 as 
antigens, affinity-purified rabbit polyclonal antisera, designated 
anti–S13-P and anti–S16-P, were generated (Fig. S1). Over-
expression of IKK- or IKK- but not IKK- increased phos-
phorylation of both unexpanded (25QP) and expanded (46QP) 
forms of Httex1p with a C-terminal His-HA-HA-His (H4) 
tag in ST14A cells cotransfected with Httex1p-H4 and IKK 
subunits (Fig. 1 D). Phosphorylation of 46QP-H4 appears less 
efficient than 25QP-H4 and phosphorylation of 25QP-H4 is 
associated with its reduced abundance. To first determine 
whether IKK can directly phosphorylate Htt and determine the 
specific residue involved, recombinant IKK phosphorylation of 
purified Htt was tested in vitro. S13 of both purified unexpanded 
(25QP) and expanded (46QP) Httex1p was phosphorylated by 
both IKK- and IKK- (Fig. 1 E), whereas phosphorylation of 
S16 was not observed (not depicted). These results suggest that 
S13 is a direct target of IKK and that the phosphorylation of 
S16 observed with IKK overexpression in cell culture may be 
primed by phosphorylation of S13 by IKK. Alternatively, the 
sensitivity of anti–S16-P antisera may be inadequate to detect 
the in vitro modification.
IKK-activated phosphorylation of 
Httex1p regulates its post-translational 
modification and subcellular localization
As described above, phosphorylation can regulate post-
 translational modification of adjacent lysine residues (Hunter, 
2007). The role of Htt S13 and S16 phosphorylation on Htt ubiq-
uitination, SUMOylation, and acetylation of Httex1p was tested. 
We previously found that 97QP Httex1p is polyubiquitinated 
and GATA-1 activates their SUMOylation (Hietakangas et al., 
2006), phosphorylation of p53 and RelA activates their acetyl-
ation (D’Orazi et al., 2002; Hofmann et al., 2002; Chen et al., 
2005), and phosphorylation of IB and FOXO3a activates 
their ubiquitination (Karin and Ben-Neriah, 2000; Karin et al., 
2002; Hu et al., 2004). In turn, these modifications may ulti-
mately target the protein for degradation (Hernandez-Hernandez 
et al., 2006; Hietakangas et al., 2006; Hunter, 2007; Wu 
et al., 2007; Zuccato et al., 2007; Jeong et al., 2009). As protein 
clearance mechanisms become impaired upon aging, modi-
fied proteins normally targeted for degradation by post-
 translational modification may accumulate and disease-causing 
proteins take on toxic functions (Orr and Zoghbi, 2007; Shao 
and Diamond, 2007).
HD is a member of a family of polyQ repeat expansion 
diseases characterized by the accumulation and aggregation of 
mutant Htt protein in diseased neurons (Orr and Zoghbi, 2007). 
In HD, when the repeat expands above 40, disease will mani-
fest, typically striking in mid-life (Walker, 2007). Above 65 
repeats, a juvenile form of the disease occurs. The polyQ 
expansion exists within the context of a large 350-kD protein; 
however, expressing just the N-terminal fragment of Htt en-
coded by exon 1 (Httex1p), which contains a highly expanded 
polyQ repeat, can precipitate an aggressive HD-like disease in 
transgenic mice and flies (Mangiarini et al., 1996; Steffan 
et al., 2001). The first 17 amino acids of Htt can mediate aggre-
gation, subcellular localization and membrane association, sta-
bility, and cellular toxicity, each of which are implicated in HD 
pathogenesis (Steffan et al., 2004; Luo et al., 2005; Warby 
et al., 2005, 2009; Anne et al., 2007; Rockabrand et al., 2007; 
Atwal and Truant, 2008). The potential for Htt post-translational 
modification to have a disease-modifying role has recently 
emerged as a consistent theme, with regulatory functions im-
plicated for other sites within the full-length protein as well, 
including phosphorylation at S421 by Akt and S434, S1181, 
and S1201 by Cdk5 (Humbert et al., 2002; Luo et al., 2005; 
Warby et al., 2005; Anne et al., 2007), SUMOylation and ubiq-
uitination at K6, K9, and K15 (Steffan et al., 2004), palmitoylation 
at C214 (Yanai et al., 2006), and acetylation at K444 (Jeong 
et al., 2009). The regulatory properties of post-translational 
modifications extend to other polyQ repeat diseases, most 
notably phosphorylation of S776 in expanded ataxin-1, the 
mutant protein in SCA1 (Orr and Zoghbi, 2007).
We evaluated the effect of phosphorylation within the 
first 17 amino acids of Htt on its subcellular localization, down-
stream post-translational modifications, and protein clearance. 
This domain contains two serines at positions 13 and 16, which 
are adjacent to the lysines found to be modified by SUMO and 
ubiquitin (Steffan et al., 2004). We demonstrate that the IKK 
complex, previously shown to directly interact with Htt (Khoshnan 
et al., 2004), phosphorylates Htt S13 and may activate phos-
phorylation of S16. Phosphorylation of these residues promotes 
modification of the adjacent lysine residues and activates Htt 
clearance in a manner requiring both the proteasome and 
lysosome. We find that expansion of the Htt polyQ repeat 
may reduce the efficiency of this phosphorylation, potentially 
contributing to the accumulation of mutant Htt.
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In addition to the detection of phosphorylation at both 
S13 and 16, acetylation of lysine K9 was detected together 
with modification of S13 by mass spectrometry upon exoge-
nous IKK overexpression (Fig. 2 C). To evaluate this acetyl-
ation further and the possible influence of phosphorylation, 
affinity-purified polyclonal antiserum was generated against a 
K9-acetyl, S13-phospho, S16-phospho Htt peptide (anti–K9-Ac; 
Fig. S1). The antibody recognizes Htt 25 or 46QP in the 
presence of exogenous IKK-; however, it shows little to no 
immunoreactivity without IKK coexpression (Fig. 2 D). Acetyl-
ation can be mimicked by a lysine (K) to glutamine (Q) substi-
tution and phosphorylation mimicked by either a serine (S) to 
aspartic acid (D) or to glutamic acid (E) substitution. Using a 
K9Q, S13,16E (QEE) mimic, immunoreactivity was observed 
in the absence of IKK, confirming the specificity of the antibody 
(Steffan et al., 2004). Making a mutant that cannot be phos-
phorylated on S13 (S13A) reduces this polyubiquitination, 
whereas mimicking phosphorylation of S13 (S13D) retains its 
polyubiquitination (Fig. 2 A). If the dual phosphorylation we 
see activated by IKK is mimicked (S13,16D), a reduction in 
Htt polyubiquitination is again observed (Fig. 2 A). Consistent 
with this, overexpression of IKK reduces polyubiquitination of 
97QP Httex1p (Fig. S2 A). The S13A and S13,16D mutants 
also demonstrate reduced mono-SUMOylation of 97QP 
Httex1p, whereas S13D retains its SUMOylation (Fig. 2 B). 
Overexpression of IKK leads to a reduction in 97QP mono-
SUMOylation and an increase in its poly-SUMOylation 
(Fig. S2 B). Therefore, IKK may modulate ubiquitin and 
SUMO addition to Httex1p, two modifications globally tied to 
protein clearance mechanisms.
Figure 1. IKK directly phosphorylates Htt. (A) The first 17 amino acids of the Htt protein contain three residues that may be phosphorylated (red) and 
three modifiable lysine residues (blue). (B) Htt S13 is within a domain similar to FOXO3a S644. (C) Mass spectrometry analysis shows that Htt serines 
13 and 16 can be phosphorylated. 25QP-HBH was purified under denaturing conditions from St14A cells cotransfected with IKK-. ESI-MS/MS spectra 
were obtained after chymotryptic digestion and collision-induced dissociation (CID) for N-terminally acetylated and diphosphorylated peptide on S13 and 
S16 Ac-ATLEKLMKAFEpSLKpSF, with the parent ion, [MH2]+2, at m/z 1023.03+2 (M = 2044.06 D). (D) Htt phosphorylation of S13 and S16, detected with 
phospho-specific antibodies, is activated with coexpression of IKK- or IKK-. Httex1p was purified from St14A cells transiently transfected with 25QP-H4 
or 46QP-H4 with vector control or plasmids encoding subunits of IKK. Total Htt was detected with CAG53b antibody, and myc-actin transfection control 
detected with anti-myc antibody. (E) IKK- and IKK- directly phosphorylate Htt S13 in vitro. An in vitro kinase assay was performed with 75 ng recombinant 
IKK- or IKK- protein, and wt (SS) or S13,16A (AA) mutant 25Q or 46Q purified Httex1p-H4. Htt was detected with CAG53b or anti-S13-P.
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Figure 2. Phosphorylation of Httex1p regulates its ubiquitination, SUMOylation, acetylation, and nuclear localization. (A and B) Phosphorylation of 
serines 13 and 16 regulates mutant Httex1p ubiquitination and SUMOylation. St14A (A) or HeLa (B) cells were transiently transfected with vector or 
HIS-ubiquitin (A) or HIS-SUMO-1 (B) and control and mutant 97QP VL* Httex1p. Conjugated proteins were purified under denaturing conditions by Ni-NTA 
magnetic nickel beads and Htt detected with anti-Htt CAG53b by Western analysis. (C) Mass spectrometry analysis shows that Htt S13 phosphorylation 
can occur with K9 acetylation. 25QP-HBH was purified from St14A cells cotransfected with IKK- and CBP and treated for 2 h with histone deacetylase 
inhibitors 200 mM Trichostatin A/5 mM Nicotinamide. ESI-MS/MS spectra were obtained after chymotryptic digestion and collision-induced dissociation 
(CID) for a peptide acetylated at K9 and phosphorylated at S13 MAcKAFEpSLKSF, [MH2]+2 at m/z 655.30+2 (M = 1308.60 D). (D) IKK- overexpression 
increases phosphorylation of Htt S13 and acetylation of K9. St14A cells were transiently transfected with Httex1p-H4 with 25 or 46Qs, +/ IKK- or with 
46QP QEE-H4. Htt was purified and subjected to Western analysis with anti-K9-Ac, anti-S13-P, and CAG53b. (E) Mimicking phosphorylation significantly 
increases nuclear localization in primary neurons. Primary cortical neurons were cotransfected with pcDNA3.1-mRFP and 97QP-GFP or 97QP-DD-GFP 
plasmids. The subcellular distribution of these polypeptides was examined by measuring the fluorescence intensity of GFP, to which they are fused, in 
regions of the nucleus and cytoplasm for each cell. The extent to which these polypeptides localized preferentially to the nucleus or the cytoplasm was 
determined by calculating the ratio of nuclear/cytoplasmic GFP fluorescence intensity and comparing the distribution of the two polypeptides by t test. Error 
bars indicate SEM in arbitrary units.
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reduction in Httex1p abundance (Fig. 3 A), which may at least 
partially be the result of its less efficient phosphorylation by 
IKK- (Fig. 1 D).
The abundance of Httex1p AA, EE, and QEE mutants 
were next compared with control Httex1p or to Httex1p in 
which all the lysines were mutated to arginine (K6,9,15R or 3R), 
also in the presence of epoxomicin or ammonium chloride/ 
leupeptin. Consistent with the potential destabilization of un-
expanded polyQ by phosphorylation, unexpanded (25QP) 
EE and QEE Httex1p levels were lower than control and AA 
(Fig. 3 C). In contrast, elimination of modifiable lysines (3R 
25QP) had no effect on soluble Htt levels, but did increase lev-
els of insoluble Htt. This result is in contrast to what we previ-
ously reported for a highly expanded 3R mutant (3R97QP; 
Steffan et al., 2004); however, we did not use filter retardation 
assays together with Western analysis to examine levels of in-
soluble Htt in those studies, and now understand that this 97QP 
3R mutant is detectable, however mostly in the insoluble frac-
tion. Inhibition of the proteasome or the lysosome increased 
levels of the unexpanded phosphomimetics (25QP EE and 
QEE), suggesting that the proteasome and lysosome may both 
be involved in clearance of phosphorylated and acetylated 
forms of unexpanded Htt fragments.
In contrast to results with unexpanded Htt, expanded con-
trol and mutant 46QP proteins accumulated in both soluble and 
insoluble fractions (Fig. 3 C, bottom); this accumulation was 
also influenced by proteasomal and lysosomal inhibition. The 
46QP EE phosphomimetic consistently ran on SDS-PAGE as a 
doublet, suggesting the presence of a phosphorylated intermedi-
ate that is not well cleared in the presence of the expanded re-
peat. The doublet was not observed with the acetylation mimetic 
QEE, implicating lysine 9 as a critical residue in this clearance 
mechanism and possibly suggesting an alternative lysine 9 post-
translational modification other than acetylation in doublet for-
mation. We conclude that expansion of the polyQ repeat in 
Httex1p reduces the efficiency of phosphorylation-activated 
IKK-mediated clearance.
To further characterize IKK-mediated Htt phosphory-
lation and clearance, a larger Htt fragment comprised of 586 
amino acids (aa) with and without IKK- (Fig. 3 D) was ex-
pressed in ST14A cells. Co-expression of IKK- significantly 
reduced levels of unexpanded Htt (586 aas with 15Qs). Al-
though there was a reduction in levels of total unexpanded 586 
(15Q) with IKK- overexpression, as determined using anti-Htt 
3B5H10 (Fig. 3 D) or anti-Htt EM48 (Fig. S4 A), a significant 
increase in an immunoreactive species was observed when the 
anti–S13-P antibody was used for detection, particularly upon 
longer-term lysosomal inhibition. Expanded repeat 128Q 586aa 
fragment levels were not reduced with overexpression of IKK-, 
and S13-phosphorylated, expanded 128Q fragment was not 
detectible above background levels, again suggesting a reduced 
ability of the mutant Htt protein to be phosphorylated and 
cleared. Collectively, these data show that IKK- can increase 
phosphorylation and reduce levels of unexpanded polyQ 
Htt fragments in a manner dependent on both the proteasome 
and the lysosome, and that expansion of the polyQ repeat 
inhibits this effect.
for this Htt species (Fig. 2 D). Collectively, these data suggest 
that IKK-mediated phosphorylation may regulate ubiquitina-
tion, SUMOylation, and acetylation within the first 17 amino 
acids of Htt.
Because the first 17 amino acids of Htt can function as 
a cytoplasmic retention signal and regulate the association 
of Htt with mitochondria, Golgi, endoplasmic reticulum, late 
endosomes, and autophagic vesicles (Steffan et al., 2004; 
Atwal et al., 2007; Rockabrand et al., 2007), and because 
overexpression of IKK- was previously demonstrated to pro-
mote expanded polyQ Httex1p nuclear localization (Khoshnan 
et al., 2004), we tested whether phosphorylation of this 
domain could influence its cellular localization. Either phospho-
mimetic (S13,16D/S13,16E or DD/EE) or phosphoresistant 
(S13,16A, or AA) forms of Httex1p were used to assess the 
consequence of phosphorylation on soluble cellular localiza-
tion. Fluorescence of mutant Httex1p with 97Qs fused to 
GFP was first assessed in NIH-3T3 cells (Fig. S3 A), demon-
strating largely cytoplasmic localization for both 97QP-GFP 
and 97QP-AA-GFP. In contrast, phosphomimetic 97QP-
 DD-GFP and 97QP-EE-GFP displayed increased nuclear 
localization. Similarly, a statistically significant increase in 
nuclear localization of expanded 97QP-DD-GFP over control 
97QP-GFP was observed upon transfection into primary 
cortical neurons (Fig. 2 E). Nuclear localization was also 
enhanced using phophomimetics of unexpanded Httex1p 
(25QP-EE-GFP) compared with wild type (wt) or AA in 3T3 
cells, suggesting this process may extend to normal Htt or Htt 
fragments (Fig. S3 B).
Phosphorylation of Htt by  
IKK activates Httex1p and 586aa Htt  
fragment clearance
We then asked whether phosphorylation by IKK might also reg-
ulate Htt stability. Unexpanded (25QP) and expanded (46QP) 
polyQ Httex1p were cotransfected into ST14A cells with IKK-, 
as this subunit of IKK had the greatest Htt phosphorylation 
activity in cell culture (Fig. 1 D), and levels of Htt evaluated. 
Unexpanded Htt showed a dependence on IKK- for enhanced 
clearance relative to a myc-actin transfection control, and this 
effect persisted in the presence of either the specific proteasome 
inhibitor epoxomicin or the lysosome inhibitors ammonium 
chloride/leupeptin (Fig. 3, A and B). Proteasome inhibitors 
were able to block basal and IKK-–induced degradation of 
25QP; however, they were not able to abolish the differences 
between both types of degradation, suggesting that the reduc-
tion in cellular levels of unexpanded 25QP Httex1p mediated 
by IKK involves proteasome-dependent and -independent 
degradation of the protein. Inhibition of the lysosome reduced 
the effect of IKK- on 25QP clearance, implicating lysosomal 
involvement. Interestingly, the IKK-–induced degradation 
of Httex1p was largely reduced for the expanded form of the 
protein, although the basal degradation of the protein was un-
perturbed and still dependent on the proteasome system. Phos-
phorylation of unexpanded polyQ Httex1p may therefore target 
it for degradation by both the proteasome and lysosome. Expan-
sion of the polyQ repeat to 46Qs inhibited this IKK-–mediated 
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Figure 3. Phosphorylation of unexpanded polyQ Httex1p and 586aa Htt is associated with its reduced abundance in cell culture. (A) Levels of un-
expanded polyQ Httex1p are reduced with overexpression of IKK-; this effect is inhibited with expansion of the polyQ repeat. 25QP-H4 or 46QP-H4 
was cotransfected with myc-actin and with vector or IKK- into St14A cells. Cells were treated for 16 h with DMSO, 100 nM epoxomicin in DMSO, or 
20 mM ammonium chloride/100 µM leupeptin in DMSO. Lysates were subjected to filter-retardation assay and Western analysis using anti-myc to detect 
myc-actin, and anti-HA to detect Httex1p. (B) IKK- overexpression reduces levels of unexpanded polyQ Httex1p in the presence of proteasome or lysosome 
inhibition. Scion software was used to quantitate triplicate levels of 25QP-H4 from the experiment represented in A, normalized to levels of myc-actin trans-
fection control, within each treatment group: control, epoxomicin, or ammonium chloride/leupeptin. (C) Mimicking phosphorylation of unexpanded polyQ 
Httex1p reduces its abundance in cell culture; this effect is reduced with expansion of the polyQ repeat. 25QP-H4 or 46QP-H4, wt control or QEE, EE, AA, 
or 3R were cotransfected with myc-actin into St14A cells. Cells and lysates were treated as in A. (D) Levels of phosphorylated unexpanded polyQ 586aa 
Htt accumulate with inhibition of the proteasome or the lysosome; phosphorylation is reduced with expansion of the polyQ repeat. 15Q or 128Q 586aa 
Htt constructs were cotransfected into St14A cells with myc-actin and with vector or IKK-. Cells were treated for 4 h with DMSO or 100 nM epoxomicin in 
DMSO (to eliminate any possible effect on the lysosome by epoxomicin), or for 16 h with water or 20 mM ammonium chloride/100 µM leupeptin in water. 
Lysates were subjected to filter-retardation assay and Western analysis using anti-myc, anti–S13-P, and anti-Htt 3B5H10.
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expression of IKK-, whereas MAB2166 does not, supporting 
the idea that the cleared Htt species may not be not recognized 
well by this antibody (Fig. S4 A).
In addition to genetic modulation of IKK, pharmacologi-
cal activation of IKK with IL-1 or TNF- was tested for acti-
vation of Htt S13 phosphorylation. ST14A cells were treated 
with these standard IKK-activating cytokines for 15, 30, 60, and 
120 min (Fig. 4 C). Both Il-1 and TNF- increased levels 
of phosphorylated full-length and fragmented Htt at 60 and 
120 min, similar to phosphorylated IB. S13-phosphorylated 
Htt and phosphorylated IB were both reduced at 15 and 30 min, 
paralleling the increased clearance of total IB at these time 
points. Total full-length Htt levels were not reduced as assessed 
by MAB2166 on Western analysis, but an 180-kD-sized set 
of N-terminal fragments recognized by anti-Htt Ab1 showed a 
possible decrease in abundance at 15 and 30 min and increased 
abundance at 60 and 120 min, similar in trend to robust effects 
on total IB. S13-phosphorylated Htt and Htt fragments accu-
mulated in cells treated for 60 and 120 min with Il-1. These 
phosphorylated Htt species accumulated even further at 120 min 
of IL-1 treatment with either epoxomicin or ammonium 
chloride/leupeptin, suggesting both proteasomal and lysosomal 
involvement (Fig. 4 D).
Endogenous S13-phosphorylated Htt was next analyzed 
by immunofluorescence. Without exogenous IKK-, only mi-
totic cells stained with anti–S13-P (Fig. 5 A), representing 
a small fraction of the cell population. In cells that were tran-
siently transfected with FLAG–IKK-, the phosphorylated 
species of Htt was detected in cells with exogenous IKK-  
expression in a variety of localization patterns (Fig. 5 B and 
Fig. S3 C). This staining was specific for phosphorylated S13, as 
it could only be competed away with a 1–17aa peptide phosphory-
lated on serine 13, but not with the corresponding unmodified 
peptide (not depicted). S13-phosphorylated Htt and K9-acetyl 
Htt immunoreactivity was also detected in FLAG–IKK-  
nucleofected mouse striatal progenitor cells, Hdh7/7 (Fig. 5 B; 
unpublished data).
Proteins involved in lysosomal and 
proteasomal clearance mechanisms modify 
levels of phosphorylated Htt
The pronounced effect of the lysosomal inhibitors on the intra-
cellular levels of phosphorylated S13 Htt compared with the 
unmodified protein (Fig. 3 D and Fig. 4, B and D), and the 
distinctive punctuate pattern observed in the immunofluores-
cence studies with the anti–S13-P antibody compatible with 
lysosomal association of the modified protein (Fig. 5 and Fig. S3 C), 
led us to further characterize the mechanism mediating the 
lysosomal degradation of S13-phophorylated Htt. Because 
lysosomal inhibition increases levels of the S13 phospho-
 species, the expectation is that proteins involved in regulating 
lysosomal activity could also influence levels of phosphorylated 
Htt. The lysosomal-associated membrane protein 2A (LAMP-2A) 
mediates selective autophagy of proteins that contain KFERQ-
like Hsc70 binding sequences in mammalian cells through 
a process known as chaperone-mediated autophagy (CMA; 
Massey et al., 2006b). Similarly, Atg7 is essential for autophagy 
Endogenous wt full-length Htt is 
phosphorylated by IKK-
The above results show that Htt fragments can be phosphory-
lated by IKK in cells and in vitro. We next examined whether 
exogenous expression of IKK subunits could phosphorylate 
full-length, endogenous wt Htt in ST14A cells to determine 
whether this type of regulation may be involved in an endoge-
nous clearance mechanism. IKK- overexpression increased the 
levels of acetylated and S13-phosphorylated full-length Htt 
and Htt fragments in ST14A cells (Fig. 4 A). To ensure that this 
effect is specific to IKK, the ability of IKK- to enhance immuno-
reactivity to both antibodies was eliminated in the presence 
of an shRNA pool against IKK- (Fig. 4 A). As a control, levels 
of phosphorylated IB, a defined IKK substrate targeted for 
degradation by its phosphorylation (Karin and Ben-Neriah, 
2000), were also evaluated in this experiment, and levels (Fig. 4 A, 
boxed) paralleled that of phosphorylated and acetylated Htt.
Full-length acetylated and phosphorylated Htt, as well as 
phosphorylated Htt fragments, were again increased by inhibi-
tion of either the proteasome or the lysosome (Fig. 4 B), sug-
gesting that they may serve as intermediates in the wt Htt 
degradation process. High molecular weight full-length S13-
phosphorylated Htt species were observed upon IKK-  
overexpression (Fig. 4 B), which may reflect full-length Htt 
post-translational modification by SUMO or ubiquitin as we 
observed for Httex1p (Fig. 2, A and B). Using a well-described 
anti-Htt antibody, MAB2166 (Millipore), which is uniquely 
sensitive enough to detect endogenous rat Htt in ST14A 
whole-cell lysate, we did not observe either a loss of endoge-
nous Htt in cells overexpressing IKK- or an accumulation 
with inhibition of the proteasome or lysosome, possibly sug-
gesting that the levels of modified Htt that are modulated 
represent a small percentage of the total. However, MAB2166 
may not interact well with the phosphorylated Htt species. 
Within the epitope recognized by MAB2166, Htt residues 
414–503, S421 (Humbert et al., 2002), and S434 (Luo et al., 
2005) are phosphorylated by Akt and Cdk5, respectively, and 
K444 is acetylated (Jeong et al., 2009). This acetylation 
at K444, involved in Htt lysosomal clearance, destroys the 
MAB2166 epitope (Krainc, D., personal communication), 
supporting the possibility that modifications eliminate reactiv-
ity with MAB2166. Although we have not determined whether 
these modifications occur at the same time as phosphorylation 
of S13 by IKK, Akt acts upstream of IKK activation (Dan 
et al., 2008) and it is possible that modification of this epitope 
concurrent with S13 phosphorylation may reduce the ability 
of MAB2166 to recognize the Htt species being cleared. 
We find that MAB2166 does not strongly recognize immuno-
precipitated S13/S16-phosphorylated or K9-acetylated Htt 
species in cells overexpressing IKK-, whereas Ab1 and 
MAB5490/1H6, antibodies that recognize the N-terminal 
domain of Htt, do recognize these modified forms (Fig. S4 B). 
In addition, Htt antibodies EM48 (recognizing the first 256 aa 
of human Htt with a deletion of the polyQ stretch [Gutekunst 
et al., 1999]) and 3B5H10 (raised against GST-human Htt 
171aa-66Q [Peters-Libeu et al., 2005]) detect reduced abundance 
of unexpanded human 15Q 586aa fragment with exogenous 
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Figure 4. Phosphorylated and acetylated endogenous wt Htt accumulates with inhibition of the proteasome and lysosome. (A) Overexpression of IKK- 
increases phosphorylation of endogenous Htt and IB in cell culture. St14A cells were transiently transfected with vector, IKK-, or IKK-, together with 
vector or two different pools of anti–IKK- shRNAs; a control pool that did not silence IKK well (pool 1) and one pool that was effective in silencing IKK 
(pool 2), as assessed by levels of FLAG-IKK- and - by Western. Lysates were subjected to Western analysis with anti-Htt MAB2166, anti–S13-P, anti–K9-Ac, 
anti-phosphoserine 32 IB (IB-P), anti–IB, anti–-tubulin, and anti-FLAG to detect FLAG-tagged IKK- and IKK-. Bands the size of full-length 
endogenous Htt (350 kD) are shown by the arrow on the left. Boxed bands show the reduction in phosphorylated IB with IKK shRNA. (B) Phosphory-
lated and acetylated Htt accumulate with inhibition of the proteasome or the lysosome. St14A cells were transiently transfected with IKK- or vector, and 
were treated as in Fig. 3 D. Lysates were subjected to Western analysis with anti–-tubulin, and anti-Htt antibodies MAB2166, anti–S13-P or anti–K9-Ac. 
(C) Pharmacological activation of the IKK complex modulates levels of phosphorylated Htt and IB. St14A cells were incubated with 20 ng/ml TNF- or 
IL-1 over a time course. Lysates were subjected to Western analysis as in A with additional detection by anti-Htt Ab1. (D) IL-1–induced Htt S13-phosphorylated 
species accumulate with inhibition of the proteasome or lysosome. St14A cells were treated for 2 h with 20 ng/ml Il-1 before lysis. The proteasome and 
lysosome were inhibited, and Western analysis performed as in B.
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Htt-mediated toxicity (Fig. 6 D) was tested. Overexpression of 
Hsc70 increased the survival of HdhQ111/Q111-expressing cells 
more than overexpression of Hsp70, the latter being 85% 
identical to Hsc70. Exogenous expression of Hsp70 or Hsc70 
showed that Hsc70, but not Hsp70, increased levels of Htt 
acetylation and S13 phosphorylation, suggesting that Hsc70 
may specifically activate an IKK-regulated Htt degradation 
process (Fig. S5). Minor differences in heat-shock proteins 
have previously been demonstrated to define their function. 
For instance, in yeast, the homologues of Hsp70/Hsc70, Ssa1p, 
and Ssa2p are 97% identical and yet only Ssa2p is required to 
target protein substrates to the yeast vacuole, the functional 
equivalent of the mammalian lysosome (Brown et al., 2000). 
We propose that Hsc70 may increase Htt clearance by the pro-
teasome and the lysosome by activating S13 phosphorylation 
and K9 acetylation.
Mimicking phosphorylation of mutant Htt in 
rat brain slice cultures reduces its toxicity
The data presented show that IKK- can enhance the level of 
a phosphorylated form of Htt that appears to be more readily 
cleared. To test whether this phosphorylation is functionally 
significant, toxicity of Htt phosphomimetics was compared 
with control expanded repeat Htt in an acutely transfected rat 
cortico-striatal slice culture model where toxicity is dependent 
on expansion of the polyQ repeat (Khoshnan et al., 2004). 
Phosphomimetic (DD) or phosphoresistant (AA) forms of 
expanded polyQ Httex1p (97QP) were tested for their effects 
and a loss of Atg7 function in mouse brain causes neuro-
degeneration (Mizushima et al., 1998; Komatsu et al., 2006). 
We therefore examined whether LAMP-2A or Atg7 might be in-
volved in the clearance of phosphorylated Htt by the lysosome. 
When either endogenous LAMP-2A or Atg7 is knocked down 
by shRNA, accumulation of endogenous S13-phosphorylated 
Htt and Htt fragments is observed (Fig. 6 A), suggesting that 
both proteins may be involved in lysosomal clearance of phos-
phorylated Htt. Likewise, shRNA against rat LAMP-2A increased 
Httex1p levels and aggregation, whereas overexpression of 
human LAMP-2A had the opposite effect (Fig. 6 B). These 
combined data are consistent with a role for LAMP-2A in the 
lysosomal clearance of Htt.
Although Httex1p does not contain a bonafide “KFERQ”-
like Hsc70-binding motif in its sequence, phosphorylation of 
Htt serine 16 (14-LKpSFQ-18) could provide the negative 
charge required to convert this sequence to an Hsc70-binding 
motif (mimic 14-LKEFQ-18, where the phosphorylated serine 
at residue 16 resembles a glutamic acid [E]). We therefore tested 
the ability of phosphomimetic Httex1p to interact with GST-
Hsc70 in vitro and found that mimicking phosphorylation of 
Htt serines 13 and 16 on unexpanded polyQ Httex1p (25QP-EE) 
increased the in vitro binding of Httex1p to Gst-Hsc70 by a 
specific ADP-dependent mechanism (Fig. 6 C, left), whereas 
expansion of the polyQ repeat to 46Qs reduced this interaction 
(Fig. 6 C, right).
Because an interaction with Hsc70 could regulate clearance 
of phosphorylated mutant Htt, the ability of Hsc70 to reduce 
Figure 5. Phosphorylated Htt can be detected by immunofluorescence in cell culture. (A) S13-phosphorylated Htt is present in untransfected mitotic rat 
S14A cells. (B) S13-phosphorylated Htt colocalizes with FLAG immunoreactivity in rat St14A cells lipofected with FLAG–IKK-, and S13-phosphorylated Htt 
colocalizes with FLAG immunoreactivity in mouse Hdh7/7 cells nucleofected with FLAG–IKK-.
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Figure 6. LAMP-2A, Atg7, and Hsc70 may modulate Htt clearance and toxicity. (A) Reducing levels of LAMP-2A or Atg7 in cell culture increases abundance 
of S13-phosphorylated Htt. St14A cells were transiently transfected with shRNA for rat LAMP-2A or Atg7, or pSUPER vector control; antibodies used for 
Western analysis are shown to the left of the Western panels. (B) LAMP-2A levels modulate Httex1p abundance. St14A cells were transiently cotransfected 
with LAMP-2A shRNA, human HA-tagged LAMP-2A or vector control, and myc-actin transfection control. Lysates were subjected to Western analysis and 
filter-retardation assay, detected with anti-Htt CAG53b, anti–rat/mouse LAMP-2A, anti-HA to detect HA-hLAMP-2A, anti-myc, and MemCode protein stain. 
(C) Hsc70 interacts with phosphomimetic unexpanded polyQ Httex1p in vitro. Purified 25QP-H4 or 46QP-H4 wt and mutant proteins radiolabeled with 
35S were incubated with isolated GST-Hsc70 or GST protein bound to glutathione-agarose beads. Where indicated, 5 mM ATP or ADP was added to the 
reaction. Bound proteins were washed, subjected to SDS-PAGE, and detected by phosphoimager autoradiography. (D) Hsc70 reduces Htt-mediated toxicity 
in Hdh111/111 cells. Hdh7/7 or Hdh111/111 cells were nucleofected with vector, Hsp70, or Hsc70 together with GFP. 47 h later, XTT cell viability assays were 
performed, and the percentage of relative survival was calculated correcting for transfection efficiency of the GFP control ± SEM from triplicates.
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is toxic, nuclear localization facilitated by phosphorylation 
could be part of a normal process of protein degradation that 
becomes impaired upon expansion of the polyQ repeat, thus 
promoting the accumulation of nuclear, toxic Htt that is impli-
cated in HD. Confirming a potential in vivo role for this modi-
fication, mutant Htt-mediated neurotoxicity was significantly 
reduced when the phosphomimetic was expressed compared 
with control or phosphoresistant mutant Htt in BACHD mice, 
 suggesting that Htt phosphorylation may slow the progres-
sion of HD in vivo and represents a valid therapeutic target 
(Gu et al., 2009).
on Htt-mediated toxicity in this model. The phosphomimetic 
97QP-DD displayed significantly reduced toxicity compared 
with either control or 97QP-AA (Fig. 7 A), suggesting that phos-
phorylation of Httex1p may reduce neurotoxicity. Because 
we showed that the phosphomimetic 97QP-DD Httex1p is 
more nuclear localized (Fig. 2 E), but is less toxic than 97QP 
in the slice cultures, the data present a potential contradiction 
to the extensive studies showing that nuclear accumulation of 
mutant Htt significantly enhances neurodegeneration (Saudou 
et al., 1998; Schilling et al., 1999; Cornett et al., 2005). These 
results suggest that while nuclear accumulation of mutant Htt 
Figure 7. Phosphorylation may reduce toxicity but 
increase insolubility of Htt. (A) Mimicking 97QP 
Httex1p phosphorylation reduces its toxicity in acutely 
transfected rat cortico-striatal slice explants. Plasmids 
encoding YFP and 97QP-CFP, 97QP DD-CFP, 97QP 
AA-CFP, or CFP control were biolistically cotransfected 
into rat cortico-striatal brain slices. The number of 
healthy medium spiny neurons in the striatal region of 
each slice was scored 5 d after transfection. n = 9 for 
each condition. Error bars represent SEM. Asterisk = 
difference from 97QP at P < 0.0001. (B) Immuno-
precipitated phosphorylated/acetylated wt Htt purified 
from mouse brain runs in an insoluble fraction in the 
SDS-PAGE stacking gel. 12 independent wt control 
(W) or R6/2 (R) mouse brains were collected at 4, 8, 
and 12 wk of age, snap frozen, and lysed. 500 µg 
of lysate was subjected to immunoprecipitation with 
PW0595 anti-Htt antibody or zero antibody control 
(lysate from lanes 12 and 13 are identical). Western 
analysis was performed with a series of antibodies 
listed to the right of the panel. Immunoprecipitated Htt 
is present as an insoluble species in the stacking gel 
and at the top of the separating gel, and as a soluble 
form at the standard 350-kD size, marked with an 
arrow. MAB2166 does not detect the insoluble spe-
cies well.
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and Fig. 3 C), which may result in reduced clearance of mutant 
Htt by inhibiting this phosphorylation-driven mechanism, and 
ultimately contribute to disease. Finally, modified species rec-
ognized by phospho- and acetyl-specific antibodies are present 
in mouse brain.
Mimicking phosphorylation of Htt serines 13 and 16 
increases soluble Httex1p-GFP nuclear localization (Fig. 2 E). 
In previous studies, we showed that Htt interacts with the acetyl-
transferase CBP (Steffan et al., 2000, 2001); therefore CBP, a 
nuclear protein, is a candidate acetyltransferase for Htt lysine 
9, as was demonstrated for lysine 444 (Jeong et al., 2009). 
CBP/p300 contains ubiquitin ligase activity which regulates 
protein degradation (Grossman et al., 2003); therefore, this E3 
ligase activity of CBP could also be involved in regulating Htt 
ubiquitination. A futher connection between the IKK-mediated 
phosphorylation of Htt and CBP activites may exist, as CBP 
interacts directly with IKK- in the nucleus (Verma et al., 
2004) and is a substrate for IKK- (Huang et al., 2007), sug-
gesting that CBP and the IKK complex could function together 
to modulate Htt stability.
Relevant to the potential role for S13 and S16 phosphory-
lation in nuclear localization, nuclear caspase-6 cleavage of 
mutant Htt has been implicated in its pathogenic potential 
(Graham et al., 2006; Warby et al., 2008). We find that IKK 
activates phosphorylation of Htt fragments, one of which is 
consistent with the predicted size of a wt Htt caspase-6 cleavage 
product (Fig. 4 B) and the fragment recently shown to be gener-
ated in neurons with activation of IKK- (Khoshnan et al., 
2009). It is therefore an intriguing possibility that phosphory-
lation by IKK ultimately promotes Htt nuclear localization, poly-
SUMOylation, acetylation by CBP, and subsequent caspase-6 
cleavage, which all facilitate a regulated form of clearance.
Phosphorylation of Htt by IKK appears to activate its deg-
radation at least in part by the lysosome, dependent on LAMP-2A 
levels (Fig. 6), the integral membrane receptor protein that 
can directly import proteins across the lysosomal membrane 
for CMA (Massey et al., 2006b). The CMA chaperone Hsc70 
preferentially interacts with phosphomimetic wt Httex1p and 
reduces Htt-mediated toxicity (Fig. 6, C and D). Combined, this 
data may suggest that phosphorylated Htt is degraded in 
a LAMP-2A–dependent mechanism through CMA. Because 
phosphorylation can trigger nuclear localization and acetylation 
of specific Htt species (Fig. 2, C–E) and overexpression of 
Hsc70 increases levels of acetylated and phosphorylated en-
dogenous full-length and fragmented Htt (Fig. S5), the findings 
implicate Hsc70 in either mediating an interaction of Htt with 
the IKK complex, or alternatively activating the IKK complex, 
as has been demonstrated for the ubiquitin ligase parkin, which 
is mutated in Parkinson’s disease (Henn et al., 2007).
CMA activity declines with age due to a gradual decrease 
of LAMP-2A levels in lysosomes (Cuervo and Dice, 2000), 
whereas artificially maintaining LAMP-2A levels in aging rat 
liver similar to those in young animals can restore CMA activity 
to youthful levels and improve organ function (Zhang and 
Cuervo, 2008). Because HD is a neurodegenerative disease asso-
ciated with aging and we have found clearance of phosphorylated 
Htt dependent on LAMP-2A, a reduction in LAMP-2A levels 
Phosphorylated and acetylated Htt can be 
detected in mouse brain
We next examined whether modified Htt species could be de-
tected in an extensively studied HD mouse model, R6/2, which 
contains two wt copies of the mouse HD gene and is transgenic 
for exon 1 of the human huntingtin gene originally carrying 
150 CAG repeats (Mangiarini et al., 1996). R6/2 mice have a 
rapid phenotypic progression (are severely impaired by 14 wk) 
and intranuclear inclusions throughout the brain. Htt was 
immunoprecipitated from whole brain tissue from 4-, 8-, and 
12-wk R6/2 versus wt control mice (Fig. 7 B; antibody PW0595, 
Enzo Life Sciences, Inc.). S13- and S16-phosphorylated and 
K9-acetylated endogenous mouse Htt showed reactivity to rela-
tively insoluble Htt species in both R6/2 and wt control brain. 
A major percentage of modified Htt remained in the stacking 
gel and at the top of the separating gel with less migrating to the 
size of the standard 350-kD full-length Htt band. No fragments 
originating from the transgene were visualized using this 
method with the modification-specific antibodies, suggesting 
that the transgene was not efficiently phosphorylated and acetyl-
ated, although it could be detected after immunoprecipititation 
with the Enzo Life Sciences, Inc. antibody (unpublished data). 
Wt Htt antibodies Ab1, MAB5490/1H6, and the Enzo Life Sci-
ences, Inc. antibody, each raised against unique Htt species, rec-
ognized wt-soluble and the insoluble Htt species in the stacking 
gel, whereas MAB2166 did not recognize the insoluble Htt, 
consistent with our data above suggesting that MAB2166 does 
not substantially detect the phosphorylated/acetylated Htt spe-
cies (Fig. S4) or that the insoluble fraction consists primarily of 
truncated N-terminal Htt species, which do not contain the 
MAB2166 epitope. We also find that Htt phosphorylated on 
threonine 3 (T3) is present in the insoluble fraction, consistent 
with our recent observation that mimicking phosphorylation of 
T3 increases Htt aggregation (Aiken et al., 2009). Overall, our 
data suggest that the S13/S16-phosphorylated and K9-acetylated 
forms of wt endogenous Htt are detectable in both wt and R6/2 
mice, and that these modified forms represent relatively insolu-
ble species.
Discussion
Delineation of Htt clearance mechanisms is of great signifi-
cance because an accumulation of mutant Htt is implicated in 
HD pathogenesis. We demonstrate that the IKK complex phos-
phorylates Htt at S13 and may activate its degradation, similar 
to IKK-mediated degradation of IB and FOXO3a (Karin and 
Ben-Neriah, 2000; Karin et al., 2002; Hu et al., 2004). The pro-
posed selective degradation of phosphorylated wt Htt, which 
involves both the proteasome and lysosome, may include a 
transient nuclear localization mediated by phosphorylation of 
Htt, where it is subsequently acetylated, ubiquitinated, and 
SUMOylated in an order that remains to be established. Proteins 
involved in lysosomal degradation pathways, Hsc70, LAMP-2A, 
and Atg7, appear to modulate the levels of these modified 
forms of Htt in mammalian cells. Our data also suggest that 
IKK-–mediated Htt S13 phosphorylation is more efficient for 
wt than for expanded polyQ truncated Htt polypeptides (Fig. 1 D 
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lysosome might actually increase HD pathogenesis through 
increased nuclear accumulation and aggregation of the mutant 
protein. At this stage of disease, serine-modified Htt would 
accumulate, leading to increased pathology as a result of the 
intrinisic toxicity of the modified Htt. Consistent with this, 
we find that mimicking Httex1p phosphorylation increases its 
toxicity and aggregation in Drosophila photoreceptor neurons 
where components of the mammalian machinery to degrade 
phosphorylated Htt, specifically LAMP-2A, are not present 
(unpublished data). Thus, during late-stage HD, it may be 
harmful to increase pathways involved in IKK activation, 
SUMOylation, and acetylation, whereas in presymptomatic 
stages, these pathways may be protective.
The Htt protein itself may play an integral role in autopha-
gic clearance of proteins. Conditional knockout of Htt in the 
mouse central nervous system results in an accumulation of 
neuropil protein aggregates containing ubiquitin and p62/
SQSTM1 (unpublished data). Htt has been shown to associate 
with autophagosomes (Atwal and Truant, 2008) and lysosomes 
(unpublished data) and may therefore play a functional and reg-
ulatory role in a selective protein clearance mechanism ulti-
mately involved in its own processing. Extensive investigation 
will be necessary to test this possibility and elucidate the pre-
cise mechanisms involved.
Materials and methods
Plasmid constructs
pcDNA3.1-based plasmids (Invitrogen) containing the Htt exon 1 DNA 
between the HindIII and BamHI sites were used as described previously 
(Steffan et al., 2004). These plasmids contained alternating CAG/CAA 
repeats, coding for either a normal range (25) or expanded (46 or 97) 
polyglutamine tracts followed by the proline-rich region of Htt ending with 
the amino acids HRP to create Httex1p. The plasmids were opened at 
BamHI and XbaI and DNA encoding various tags was inserted in frame 
with Httex1p to create C-terminal tagged Httex1p. The following tags were 
used: GS*, VL*, HBH (a gift from Peter Kaiser and Christian Tagwerker, 
University of California, Irvine, Irvine, CA [Tagwerker et al., 2006]), EGFP, 
and H4 (HIS-HA-HA-HIS: GSHHHHHHMGYPYDVPDYAEFYPYDVPDYAVH-
HHHHH*) where a stop codon is denoted by the asterisk. The H4 tag was 
created by a two-step double-stranded oligonucleotide ligation.
Mutations in Httex1p were created using double-stranded oligo-
nucleotides containing HindIII-compatible ends encoding the first 17 amino 
acids of Huntingtin, which were ligated between the HindIII site of 
pcDNA3.1 in the polylinker and the HindIII site in exon I, immediately 5 
to the CAG repeat. K6R K9R K15R (3R) was used as described previously 
(Steffan et al., 2004). To create S16 mutations, the HindIII site was shifted 
using oligonucleotides containing BspMI (BfuAI) sites, then double-stranded 
oligonucleotides were again used to create S13 together with S16 mu-
tants. pHsc70 was constructed by ligating the BamHI fragment from pGST-
Hsc70 encoding Hsc70 into the BamHI site of pcDNA3.1. For plasmids 
used in the acutely transfected striatal slice culture assay, 97QP Httex1p wt 
and mutants were cloned into pGWIZ (Gene Therapy Systems) in frame 
with CFP using the PstI site.
The following plasmids were obtained collaboratively or as gifts: 
pHis-SUMO-1 (A. Dejean, Institut Pasteur, Paris, France); pHis-Ubiquitin 
(D. Bohmann, University of Rochester, Rochester, NY); p-human-HA-LAMP-2A 
(pAMC1) and pGST-Hsc70 (A.M. Cuervo, Albert Einstein College of Medi-
cine, Bronx, NY; Cuervo and Dice, 1996); pCMV-Hsp70 (P. Muchowski 
[University of California, San Francisco, San Francisco, CA] and H. Kamp-
inga [University of Groningen, Groningen, Netherlands; Michels et al., 
1997); pMyc-Actin (H. Rommelaere, Ghent University, Ghent, Belgium); 
pFLAG-IKK, pFLAG-IKK, and pHA-IKK (A. Khoshnan and P. Patterson, 
California Institute of Technology, Pasadena, CA); pYFP (L. Kaltenbach and 
D. Lo; Duke University, Durham, NC); 586aa Htt constructs 15Q (pCI-
NeoHtttt586-15) and 128Q (pCINeoHtt 586–128; M. Hayden, University 
of British Columbia, Vancouver, Canada); pcDNA3.1-CBP (A. Kazantsev 
over time may be tied to HD pathogenesis. We propose a hypo-
thetical model for the progression of HD at the molecular level 
(Fig. 8), where IKK phosphorylates Htt and activates a cascade 
of Htt post-translational modifications and caspase cleavage 
(Khoshnan et al., 2009) associated with rapid Htt degradation 
by the proteasome and the lysosome in unaffected neurons. In a 
presymptomatic HD neuron, IKK could be induced by the pres-
ence of the mutant protein (Khoshnan et al., 2004), thus stimu-
lating an IKK-mediated mechanism of Htt clearance, consistent 
with the innate immune activation that occurs in premanifest 
patients well before symptom onset (Björkqvist et al., 2008). 
As long as LAMP-2A levels remain high, patients can degrade 
mutant Htt before it can cause toxicity, despite progressively 
inhibited proteasome activity and reduced efficiency of mutant 
Htt phosphorylation. As aging and mutant Htt together progres-
sively impair proteasome and overall lysosomal activity, and as 
LAMP-2A levels decline with age, modified Htt may accumu-
late, enhancing HD pathogenesis.
From this model, it follows that increasing the efficiency 
of Htt clearance by the lysosome, or increasing levels or mobil-
ity (Kaushik et al., 2006) of functional LAMP-2A in the lyso-
somal membrane early in the disease process, could delay HD 
onset and serve as a therapeutic strategy. Treatment choice may 
vary depending on the stage of HD. In mammals, early treatment 
to increase Htt phosphorylation and acetylation may be useful 
when levels of LAMP-2A are adequate, as suggested by the 
reduced toxicity in acutely transfected rat slice cultures (Fig. 7 A) 
and complete lack of neurotoxicity in BACHD mice when Htt is 
mutated to mimic the phosphorylated form (Gu et al., 2009). 
However, when LAMP-2A levels are low or its function is im-
paired, drugs that activate the formation of the post-translationally 
modified Htt species normally targeted for degradation by the 
Figure 8. Proposed molecular mechanism for the development of HD. 
Normal neuronal function: IKK phosphorylates wt Htt activating its post-
translational modification, caspase cleavage, and clearance by the protea-
some and lysosome. Presymptomatic HD neuronal function: With chronic 
expression of mutant Htt, proteasome activity is reduced, and lysosomal 
degradation of mutant Htt becomes essential. Mutant Htt triggers activa-
tion of the IKK complex; however, it is less efficiently phosphorylated than 
wt Htt. With the clearance mechanism activated, mutant and wt Htt in the 
presymptomatic cell are degraded by the lysosome. Symptomatic HD neu-
ronal function: Lysosomal degradation of Htt is impaired through reduction 
of LAMP-2A levels or other loss of lysosomal function caused by aging and 
by mutant Htt expression. Uncleared mutant Htt and Htt fragments accumu-
late and take on toxic functions, enhancing HD pathogenesis.
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Research Laboratories, Inc.) and anti–mouse conjugated with FITC (Jackson 
ImmunoResearch Laboratories, Inc.), and they were used at 1:1,000. 
Slides were stained with DAPI to detect nuclei. ProLong Gold Antifade 
(Invitrogen) imaging medium was used. Images were collected at room 
temperature with an inverted microscope (Observer.Z1; Carl Zeiss, Inc.) 
with a Plan-Apochromat 63X objective, NA 1.40. AxioVision AxioVs40 
v 4.7.1.0 software (Carl Zeiss, Inc.) was used to generate 3D deconvoluted 
images. The camera used was an AxioCam MRm (Carl Zeiss, Inc.).
Protein purification and Western analysis
His-tagged proteins were purified under denaturing conditions using 
magnetic Ni-NTA nickel beads (QIAGEN) as described previously (Steffan 
et al., 2004) for Fig. 1 D, Fig. 2, A and B, and Fig. S2, A and B. Western 
blots were processed with SuperSignal West Pico and Dura reagents 
(Thermo Fisher Scientific). Quantitative densiometric analyses (Fig. 6 A 
and Fig. S4) were performed on digitalized images of immunoblots using 
Scion Image 4.0 software (Scion Corporation) and SEM calculated from 
densiometric levels of Western signal from triplicate preparations of protein 
extracts. Densitometric levels of phosphorylated or acetylated Htt protein 
were normalized to levels of -tubulin loading control. Filter retardation as-
says were performed as follows: Cell debris pellets were taken after centrif-
ugation for 10 min at 16,000 g. Pellets were resuspended in 100 µl of Tris 
buffer (20 mM Tris and 15 mM MgCl2 at pH 8.0) and 100 µl of 4% SDS-
100 mM DTT in PBS was added. These samples were boiled for 5 min and 
then filtered through nitrocellulose membrane via a dot-blot apparatus. The 
membranes were then dried at room temperature for 30 min, stained with 
MemCode reversible protein stain (Thermo Fisher Scientific), blocked, and 
primary antibodies were added for Western analysis. Native buffer A, 
used for lysis of cells in Figs. 3, 4, 6, S3, S4, and S5: 10 mM Tris-HCl, 
pH 7.5, 10% glycerol, 400 mM NaCl, 1 mM EDTA, 1 mM PMSF, 0.5% 
NP-40, 20 mM N-ethylmaleimide, 1 mM PMSF, phosphatase inhibitors 1 and 2 
(Sigma-Aldrich), complete mini protease inhibitor pellet (Roche), 10 ng/ml 
aprotenin, 10 ng/ml leupeptin, 5 mM nicotinamide and 5 mM butyrate, 
pH 7.5. Native buffer B, used for purification in Fig. 2 D: 50 mM NaH2PO4, 
pH 8.0, 150 mM NaCl, 0.1% Tween 20, 1 mM DTT, 5 mM ADP, 10 mM 
Imidazole, 1 mM PMSF, 10 ng/ml aprotenin, 10 ng/ml leupeptin, com-
plete mini protease inhibitor pellet (Roche), and phosphatase inhibitors 
1 and 2 (Sigma-Aldrich). All St14A cells used in Westerns showing phos-
phorylated Htt were treated with phosphatase inhibitor Calyculin A (Enzo 
Life Sciences, Inc.) 10–30 min (20 nM) before lysis.
In vitro kinase assay
The in vitro kinase assay was performed as described previously (Liu et al., 
2007) using 75 ng recombinant IKK- or IKK- protein (Millipore) and 
25QP-H4 or 46QP-H4 purified from St14A cells using magnetic Ni-NTA 
nickel beads (QIAGEN) under native conditions with the following buffers. 
Lysis buffer: 50 mM NaH2PO4, pH 8.0, 300 mM NaCl, 10 mM imidazole, 
0.05% Tween 20, 1 mM PMSF, 10 ng/ml aprotenin, 10 ng/ml leupeptin, 
and phosphatase inhibitors 1 and 2 (Sigma-Aldrich). Wash buffer: 50 mM 
NaH2PO4, pH 8.0, 300 mM NaCl, 20 mM imidazole, 0.05% Tween 20, 
and phosphatase inhibitors 1 and 2 (Sigma-Aldrich). Recombinant IKK was 
diluted in enzyme dilution buffer: 20 mM MOPS/NaOH, pH 7.0, 1 mM 
EDTA, 5% glycerol, 0.01% Brij35, 0.1% -mercaptoethanol, and 1 mg/ml 
BSA. The kinase assay was performed in 5X kinase buffer: 40 mM MOPS/
NaOH, pH 7.0, and 1 mM EDTA. Before the assay, purified Htt bound to 
Ni-NTA beads was incubated at 95°C for 3 min, and then placed on ice 
for 5 min. The assay was performed at 30°C with light agitation for 10 min 
under the following conditions: 2.5 µl recombinant IKK subunit, 5 µl 5X 
kinase buffer, 2.5 µl 1 mM ATP, 2.5 µl 0.1 M MgAc, and 12.5 µl purified 
Htt in water. The assay was stopped with addition of Western sample load-
ing buffer, boiled 10 min, run on 12% SDS-PAGE, and Western analysis 
was performed.
Mass spectrometry analysis
ST14A cells were transiently transfected with Htt25QP-HBH + IKK-  
(Fig. 1 C) or Htt25QP-HBH + CBP + IKK- (Fig. 2 C); 48 h after transfection, 
the cells reached confluency. Cells were then treated with fresh media contain-
ing 10 nM Calyculin A (EMD) for 30 min, or 20 nM Calyculin A (Enzo Life 
Sciences, Inc.) for 10 min. Cells were washed with cold 1x PBS, then har-
vested and lysed in 1 ml lysis buffer each (50 mM Tris-HCl, pH 8.0, 8 M 
urea, 500 mM NaCl, 50 mM NaH2PO4, 10 mM imidazole, 0.5% Triton 
X-100, and complete mini protease inhibitor [Roche]). The DNA was sheared 
and the cells further lysed by passing through a 20-guage needle 20 times, 
and cellular debris was removed by centrifugation. Clarified lysates were 
then incubated with 25 µl Ni-Sepharose 6 Fast Flow (GE Healthcare) or 
Ni-NTA magnetic nickel (QIAGEN) bead slurry for 3 h or overnight at 
and D. Housman, Massachusetts Institute of Technology, Cambridge, MA; 
Kazantsev et al., 1999); pcDNA3.1-mRFP (S. Finkbeiner, University of 
California, San Francisco, San Francisco, CA); and pcDNA3-CHIP and 
pcDNA-CHIPUbox (C. Patterson, University of North Carolina at Chapel 
Hill, Chapel Hill, NC; Jiang et al., 2001).
shRNA for rat Atg7 5-GAAGTACCACTTCTACTAC-3was cloned 
into pSUPER vector (Appllied Biosystems). shRNA for rat LAMP-2A, 
5-GACTGCAGTGCAGATGAAG-3 in pSUPER was previously constructed 
(Massey et al., 2006a). IKK pool 1 contained the following shRNAs 
in pLKO.1 (Addgene): 5-CCGGGCACTGGGAAAGTATCTGAAACTCGAGT-
TTCAGATACTTTCCCAGTGCTTTTT-3, 5-CCGGCCAGCCAAGAAGAGTG-
AAGAACTCGAGTTCTTCACTCTTCTTGGCTGGTTTTT-3, 5-CCGGCTTAC-
CTGAATCAGACAAGAACTCGAGTTCTTGTCTGATTCAGGTAAGTTTTT-3, 
5-CCGGGCATCTAGTAGAGCGGATGATCTCGAGATCATCCGCTCTACT-
AGATGCTTTTT-3, 5-CCGGCGTTGTTAGTGAAGACTTGAACTCGAGTTC-
AAGTCTTCACTAACAACGTTTTT-3. IKK pool 2 shRNAs in pLKO.1 were: 
5-CCGGGCATCATAAGGAGTTGGTGTACTCGAGTACACCAACTCCT-
TATGATGCTTTTT-3, 5-CCGGCCAGATTATGAAGAAGTTGAACTCGAGT-
TCAACTTCTTCATAATCTGGTTTTT-3, 5-CCGGCCAGCCTCTCAATGT-
GTTCTACTCGAGTAGAACACATTGAGAGGCTGGTTTTT-3, 5-CCGGGC-
AAATGAGGAACAGGGCAATCTCGAGATTGCCCTGTTCCTCATTTGC-
TTTTT-3, 5-CCGGGCGTGCCATTGATCTATATAACTCGAGTTATATAGATC-
AATGGCACGCTTTTT-3.
Cell culture and transfections
The Hela, St12.7, ST14A, and N548mu and the wild-type STHdhQ7/HdhQ7 
and homozygous mutant STHdhQ111/HdhQ111 cell lines were propagated 
as described previously (Steffan et al., 2004; Apostol et al., 2008). NIH-
3T3 cells were grown in DMEM and 10% newborn calf serum (Hyclone). 
All cells were transfected with Lipofectamine 2000 according to the manu-
facturer’s instructions (Invitrogen) except STHdhQ7/HdhQ7, which were nucleo-
fected. rhTNF- and rmIl-1 (R&D Systems) were used to pharmacologically 
activate IKK.
Primary antibodies
Three affinity-purified rabbit polyclonal antibodies were generated 
(New England Peptide) against post-translationally modified 1–17aa 
Htt peptides. Antibodies were generated against the following peptides: 
anti-S16-P: H2N-CMATLEKLMKAFESLK(pS)F-amide; anti-S13-P: H2N- 
CMATLEKLMKAFE(pS)LKSF-amide; anti-K9-Ac: Ac-CLEKLM(Ac-K)AFE(pS)LK 
(pS)F-amide. Two rabbits were immunized with each peptide; antisera were 
pooled and run over an unmodified Htt 1–17aa peptide column (affinity 
matrix 20401; Thermo Fisher Scientific) to remove antibodies recognizing 
unmodified Htt species. The flow-through from each was then run over the 
modified peptide column for each respective project. The elutions from 
these columns were used as the modification-specific antibodies for this 
study, and tested for specificity using a peptide dot blot (Fig. S1). These 
three antibodies were also tested on Westerns of lysates from Hdh7/7 and 
Hdh111/111 cells nucleofected with IKK or vector +/ siRNA for Htt (a gift 
from R. Friedlander, Brigham and Women’s Hospital, Boston, MA); levels 
of antigenic species were reduced with Htt siRNA in both cell lines, dem-
onstrating modified Htt specificity. JG1 is another rabbit polyclonal anti-Htt 
1–17aa antibody generated by our laboratory.
We also used the following antibodies for this work: CAG53b (a gift 
from E. Wanker, Max Delbrueck Center for Molecular Medicine, Berlin, 
Germany); anti-Htt PW0595 (Enzo Life Sciences, Inc.); anti-Myc 9E10 
(Millipore); anti-FLAG (Sigma-Aldrich), anti-HA 16B12 (Covance); anti–
-tubulin clone B-5-1-2 (Sigma-Aldrich); anti-Htt Ab1 (M. DiFiglia, Harvard 
University, Cambridge, MA); anti-Htt EM48 MAB5374 (Millipore); anti-Htt 
1H6 (Abnova; Fig. S4); anti-Htt MAB2166 (Millipore); anti-Htt MAB5490 
(Millipore; Fig. 7); anti-Htt 3B5H10 (S. Finkbeiner, Univeristy of California, 
San Francisco); anti–rat LAMP-2A Igp96 (Invitrogen); anti-nestin (Millipore); 
anti-Atg7 (Abcam); anti–SUMO-1 (PW9460; Enzo Life Sciences, Inc.), 
anti-ubiquitin (13–1600, Invitrogen; and sc8017, Santa Cruz Biotechnol-
ogy, Inc.); anti-IB clone IB-245 (Invitrogen); anti–phospho-IB Ser 32 
14D4 (Cell Signaling Technology); and anti-phosphorylated Htt threonine 3 
[anti-T3-P; Aiken et al. [2009]). Secondary antibodies used for Western 
analysis were goat anti–mouse HRP (The Jackson Laboratory) and goat 
anti–rabbit HRP (Thermo Fisher Scientific).
Immunofluorescence analysis
Cells were transfected (Lipofectamine 2000) or nucleofected (Lonza) with 
IKK- (1/2 IKK- and 1/2 pcDNA) and 24 h later fixed at room tempera-
ture with 4% PFA, permeabilized, and blocked with 5% BSA and 4% don-
key serum. Primary antibodies were diluted at 1:1,000. Secondary 
antibodies were anti–rabbit conjugated with Cy3 (Jackson Immuno-
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phosphate with plasmids at 5 d in vitro, as described previously (Xia et al., 
1996; Finkbeiner et al., 1997). Specifically, neurons were cotransfected 
with pcDNA3.1-mRFP (Arrasate et al., 2004) and 97QP-GFP or 97QP-PP-
GFP in a 1:1 molar ratio using a total of 3 µg of DNA in each well of a 
24-well plate. After transfection, neurons were maintained in serum-free 
medium with Forskolin (10 µM; Sigma-Aldrich) and IBMX (100 µM; Sigma-
Aldrich). Neurons were fixed with 4% paraformaldehyde in PBS (15 min) 
20 h after transfection, permeabilized with 0.1% Triton X-100 in PBS 
(30 min), and incubated with 1 M glycine in PBS (20 min). Finally, neurons 
were washed twice for 5 min each with 2.5 µg/ml of Hoechst 33258 in 
PBS dye to stain the nuclei.
Robotic microscope imaging system. The microscope imaging system 
has been described previously (Arrasate et al., 2004; Arrasate and 
Finkbeiner, 2005). Basically, the system is based on an inverted microscope 
(TE300 Quantum; Nikon). Xenon lamp (175 W) illumination was supplied 
by a liquid light guide. The Nikon working distance objective 20X (NA 
0.45) was used. Fluorescence excitation and emission filters were moved 
into or out of the optical path by two ten position filter wheels (Sutter Instru-
ment Co.) under computer control. Images were collected with a 12/14 bit 
digital cooled CCD camera (Orca II; Hamamatsu Photonics) and digitized 
with MetaMorph software (Universal Imaging). Before image acquisition, 
care was taken to adjust the gain and offset of the camera and the analogue-
to-digital converter to ensure that the intensities of all the pixels of each im-
age were within the detection range of the instrument, and that the settings 
were the same across the samples that were examined. The whole system 
is mounted on a vibration isolation table.
Image analysis. Measurements of htt expression were extracted from 
images generated with the microscope imaging system described above. 
The validity of estimating htt expression levels in live cells from images of 
the fluorescence of the GFP fusion tag to which it is fused has been demon-
strated previously by directly comparing this approach to other methods 
that are highly quantitative but unsuitable for live-cell imaging (Arrasate 
et al., 2004). The expression of 97QP-GFP or 97QP-DD-GFP was estimated 
by measuring GFP fluorescence intensity within a region of interest from the 
image that corresponded to a portion of the cytoplasm or the nucleus in 
neurons that had not developed inclusion bodies. Hoechst staining was 
used to localize the nucleus. Pixel intensities within a similar sized region 
from an adjacent acellular portion of the image were collected as a mea-
surement of background signal. Pixel values from these background 
measurements were subtracted from the corresponding pixel intensity 
measurements made from the nucleus and the cytoplasm. These calcula-
tions produced background-corrected measurements of htt 97QP-GFP or 
97P-DD-GFP from the cytoplasm and nucleus.
Statistical analysis. The ratio of GFP intensity in the nucleus over 
the cytoplasm was calculated for individual neurons by dividing the 
background-corrected pixel intensities from the region of interest within the 
nucleus by the background-corrected pixel intensities from the region of in-
terest within the cytoplasm of the same neuron. Differences in the mean of 
these ratio measurements were compared by t test with commercially avail-
able software (Prism 3.0; GraphPad Software, Inc.).
Htt immunoprecipitation from mouse brain
Age-matched R6/2 and wt control brains were collected and snap frozen. 
Whole brain tissue was dounced 20 times on ice in T-Per lysis buffer 
(Thermo Fisher Scientific) containing an EDTA-free mini protease inhibitor 
pellet (Roche), a Phos-Stop pellet (Roche), 5 mM sodium fluoride, and 
1 mM sodium orthovanadate. Lysates were microfuged at 16,000 g at 4°C 
for 15 min, and the supernatant saved. Htt was immunoprecipitated from 
the 500 µg of supernatant using Protein G-Plus Agarose (Santa Cruz 
Biotechnology, Inc.) with 1 l PW0595 antibody (Enzo Life Sciences, Inc.) 
or zero antibody control, and run on 8% SDS-PAGE and blotted to nitro-
cellulose for standard Western analysis.
Online supplemental material
Fig. S1 shows the specificity of the modification-specific antibodies. Fig. S2 
shows the role of IKK in the regulation of mutant Httex1p ubiquitination and 
SUMOylation. Fig. S3 shows cellular localization of phosphorylated Htt. 
Fig. S4 shows loss of an epitope for popular anti-Htt antibody MAB2166 
with post-translational modification of Htt. Fig. S5 shows the role of Hsc70 
and the ubiquitin ligase CHIP in the regulation of levels of phosphorylated 
and acetylated Htt. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.200909067/DC1.
room temperature. The beads were then washed twice in the lysis buffer, 
and four times with wash buffer (50 mM Tris-HCl, pH 6.3, 8 M urea, 500 mM 
NaCl, 50 mM NaH2PO4, 20 mM imidazole, and 0.5% Triton X-100). The 
beads of the same condition were pooled and the urea buffer was 
replaced with 50 mM NH4CO3 before digestion.
Chymotryptic digestion (2% by weight) of 25QP-HBH was per-
formed on the Ni beads used to purify the protein to maximize peptide re-
covery. The digestion occurred overnight at 37°C. Resulting peptides were 
extracted from the beads with 25% acetonitrile, 0.1% formic acid three 
times. The extracts were pooled, concentrated using a SpeedVac, and 
acidified by 0.1% formic acid before mass spectrometric analysis. Resul-
tant peptides were then separated and analyzed by reverse-phase liquid 
chromatography coupled to tandem mass spectrometry (LC MS/MS) on 
a quadropole-orthogonoal-time-of-flight tandem (Guerrero et al., 2008) 
(QSTAR XL; Applied Biosystems/PE Sciex) or an ultra-high performance 
Thermo Electron linear trap quadropole (LTQ)-Orbitrap hybrid (Fang et al., 
2008) (Thermo Fisher Scientific) mass spectrometer.
Extraction of the monoisotopc masses (m/z) of parent ions, their 
charge states, and their corresponding fragment ions was performed auto-
matically using Analyst software (Applied Biosystems) for QSTAR data or 
using extract MSn (Matrix Science) for LTQ-Orbitrap data. These data were 
then submitted for automated database searching for protein identification 
using the Protein Prospector (University of California, San Francisco) search 
engine. Post-translational modifications were confirmed by manual inspec-
tion of the MS/MS spectra.
GST pull-down assay
For GST pull-down assays, 35S-labeled His-tagged Httex1p-H4 proteins 
were synthesized in a TNT coupled reticulocyte lysate system (Promega), 
purified, and eluted under native conditions using magnetic Ni-NTA nickel 
beads (QIAGEN) in the buffers suggested by the manufacturer. The eluted 
proteins were dialyzed using SlideALyzer 3.5K Dialysis Casettes (Thermo 
Fisher Scientific) against 20 mM MOPS, pH 7.3/0.25 M sucrose buffer. 
GST-Hsc70 was purified from Escherichia coli using glutathione-agarose 
beads, and incubated with purified radioactive Httex1p-H4 proteins in 
20 mM Tris-HCl, pH 7.2, 150 mM NaCl, 0.1% Tween 20, and 1 mM DTT 
supplemented with ATP or ADP corresponding to the incubation conditions, 
washed five times, and subjected to SDS-PAGE and autoradiography.
Toxicity assays
For XTT cell viability assays, STHdhQ7 and STHdhQ111 and cell lines were 
plated in 24-well plates (0.75 × 105 cells per well) in complete media as 
described previously (Apostol et al., 2008). The next day, cells were shifted 
to nonpermissive conditions (i.e., 39°C and low serum media) for 48 h 
for STHdhQ111 and STHdhQ7 lines followed by incubation for 4 h with XTT 
and phenazine methosulfate (0.2 mg/ml and 0.2 µg/ml, respectively; 
Sigma-Aldrich) for 4 h, and plates were read at 450 nM.
Rat cortico-striatal brain slice neurodegeneration assay
All animal experiments were performed in accordance with the Institu-
tional Animal Care and Use Committee and Duke University Medical Cen-
ter Animal Guidelines. Brain slice preparation and biolistic transfection 
were performed as described previously (Lo et al., 1994; Southwell et al., 
2008) with some modifications. In brief, brain tissue was dissected from 
postnatal day 10 CD Sprague Dawley rats (Charles River Laboratory) and 
placed in ice-cold Neurobasal A culture medium containing 10% heat-
 inactivated pig serum, 5% heat-inactivated rat serum (Lampire), 10 mM KCl, 
10 mM Hepes (Sigma-Aldrich), 1 mM sodium pyruvate (Sigma-Aldrich), 
100 U/ml penicillin/streptomycin, and 1 mM l-glutamine. All media 
reagents were obtained from Invitrogen unless otherwise noted. Brain 
tissue was cut into 250-µm-thick coronal slices using a Vibratome and in-
cubated for 30 min at 32°C/5% CO2 before biolistic transfection. Gold 
particles (1.6 µm; Bio-Rad Laboratories) were coated with the indicated 
plasmids, loaded into Tefzel tubing (McMaster-Carr), and transfected with 
the Helios Gene Gun (Bio-Rad Laboratories) at 95 psi. Brain slices were 
incubated at 32°C/5%CO2 until analysis at 5 d post-transfection. Medium 
spiny neurons were visualized by fluorescence microscopy of YFP and 
scored by neuron morphology. Medium spiny neurons were considered 
healthy if they were of uniform size and shape and contained visible den-
drites. Data were analyzed with Prism software (GraphPad Software, Inc.) 
and significance was determined by unpaired Student’s t test.
Calculation of the nucleus/cytoplasm ratio for 97QP-GFP versus 97QP-DD-GFP
Cell culture and transfection. Primary cultures of rat cortical neurons were 
prepared from embryonic rats (E 19–20) and transfected using calcium 
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